天龍集團(300063.SZ):6名董事、高管擬合計減持不超0.41%股份
格隆匯10月9日丨天龍集團(300063.SZ)公佈,公司於2020年10月9日收到公司部分董事和高級管理人員出具的《減持股份計劃》。副總經理王娜、董事兼副總經理梅琴、董事陳東陽、董事廖星、副總經理姚鬆、董事會祕書王晶擬通過集中競價交易和大宗交易合計減持公司股份不超過306萬股,即不超過公司總股本的0.41%。
其中,擬通過集中競價交易方式進行減持的,將於該減持計劃公告之日起15個交易日之後的六個月內實施(根據法律法規禁止減持的期間除外);擬通過大宗交易方式進行減持的,將於該減持計劃公告之日後的六個月內實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.